GLP-1 Agonists Show Possible Benefits for Rare Blood Cancer

(MedPage Today) — HOUSTON — Patients with polycythemia vera (PV) and a history of treatment with GLP-1 agonists had significantly lower rates of multiple adverse outcomes associated with the disease, a large propensity-matched study showed…

Why GLP‑1 drugs should be covered beyond weight loss

When I turned 50, I weighed 265 pounds. Over the next 12 years, through walking, yoga, and strength training, I lost 60 pounds and kept it off. But despite the discipline, I remained plagued by inflammation, pain, and sleep apnea. Then last year, my doctor suggested tirzepatide (Zepbound), not just for weight loss but to […]

Weight-loss drug semaglutide shown to reduce cocaine use in rats

Scientists have found that the diabetes/weight loss drug semaglutide, sold commercially under brand names like Ozempic and Wegovy, significantly reduces cocaine-seeking behavior in rats. This work needs to be confirmed in humans, but it suggests that semaglutide is a candidate to be developed as a treatment for cocaine dependency; at the moment there is no effective pharmacological treatment for cocaine dependency.

MeAgain – Navigate your GLP-1 Journey

MeAgain is designed specifically for people on GLP-1 medications like Ozempic®, Wegovy®, Mounjaro®, Zepbound®, generics and compounds. MeAgain helps you build and stay on track with your new habits, manage side effects, and ensure you feel like you again soon. View startup

How Glucagon-Like Peptide-1 Medications Are Depicted in Instagram Posts Regarding Women’s Health, Nontraditional Access, and Barriers to Access: Content Analysis

Background: Glucagon-like peptide-1 (GLP-1) medications, recently introduced in the United States for treating type 2 diabetes and obesity, have sparked interest and discussion on social media. Social media has emerged as a prominent platform for the distribution of health information; its vast user base and accessibility make it a popular resource for individuals seeking medical […]